|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2008-11-5
|
|
pubmed:abstractText |
Stavudine (d4T) is a potent but potentially toxic nucleoside reverse transcriptase inhibitor that is still widely used in developing countries. This study's aim was to determine the efficacy and safety profile of lower-dose d4T.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1468-1293
|
|
pubmed:author |
pubmed-author:Ait-MohandHH,
pubmed-author:AmellalBB,
pubmed-author:BehinAA,
pubmed-author:BennatDD,
pubmed-author:BonmarchandMM,
pubmed-author:CalvezVV,
pubmed-author:GuiguetMM,
pubmed-author:KatlamaCC,
pubmed-author:MarguetFF,
pubmed-author:MurphyRR,
pubmed-author:PeytavinGG,
pubmed-author:PialouxGG,
pubmed-author:SlamaLL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
738-46
|
|
pubmed:meshHeading |
pubmed-meshheading:18651858-Adult,
pubmed-meshheading:18651858-Aged,
pubmed-meshheading:18651858-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18651858-CD4 Lymphocyte Count,
pubmed-meshheading:18651858-Drug Administration Schedule,
pubmed-meshheading:18651858-Female,
pubmed-meshheading:18651858-HIV Infections,
pubmed-meshheading:18651858-HIV-1,
pubmed-meshheading:18651858-Humans,
pubmed-meshheading:18651858-Male,
pubmed-meshheading:18651858-Middle Aged,
pubmed-meshheading:18651858-Pilot Projects,
pubmed-meshheading:18651858-RNA, Viral,
pubmed-meshheading:18651858-Reverse Transcriptase Inhibitors,
pubmed-meshheading:18651858-Stavudine,
pubmed-meshheading:18651858-Treatment Outcome,
pubmed-meshheading:18651858-Viral Load
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study.
|
|
pubmed:affiliation |
Service de Maladies Infectieuses et Tropicales, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
